What is Tetracore?
Tetracore, Inc. is at the forefront of developing advanced diagnostic solutions tailored for animal health, domestic preparedness, and the critical area of biothreat detection. Their comprehensive suite of offerings includes a diverse range of assays, reagents, and sophisticated instruments designed to accurately identify infectious diseases and biological threat agents. Serving a broad clientele across veterinary health, forensic biology, and human health sectors, Tetracore leverages over two decades of specialized experience to deliver best-in-class solutions and actionable intelligence to its partners, reinforcing its position as a leader in biosafety and biosecurity.
How much funding has Tetracore raised?
Tetracore has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Tetracore?
The recent major strategic investment into Tetracore, following a substantial enterprise-level funding context, indicates a strong market validation and a clear trajectory for accelerated expansion. This capital infusion is expected to fuel further innovation in their diagnostic product lines, enhance their service capabilities, and potentially broaden their market reach into new territories or applications. Tetracore is poised to leverage this financial momentum to solidify its leadership in animal health and biothreat detection, driving advancements in public and animal safety.
See full Tetracore company page
